Rhinocerebral mucormycosis in patients with burns: Case report and review of the literature

Journal of Burn Care and Rehabilitation

Volumn 20, Issue 4, 1999, Pages 303-306

  Stern, Lawrence E ^a   Kagan, Richard J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; AUTOPSY; BRAIN INFECTION; BURN; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DIABETES MELLITUS; HUMAN; HUMAN TISSUE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MALE; MUCORMYCOSIS; OPPORTUNISTIC INFECTION; PARENTERAL DRUG ADMINISTRATION; RISK FACTOR;

EID: 0032779230     PISSN: 02738481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004630-199907000-00005     Document Type: Article

References (33)

1. Cocanour CS, Miller-Crotchett P, Reed RL, Johnson PC, Fischer RP. Mucormycosis in trauma patients. J Trauma 1992;32:12-5.
2. Kraut EJ, Jordan MH, Steiner CR. Arterial occlusion and progressive gangrene caused by mucormycosis in a patient with burns. J Burn Care Rehabil 1993;14:552-6.
3. Elgart ML. Zygomycosis. Dermatol Clin 1996;14:141-6.
4. Parfrey NA. Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases. Medicine (Baltimore) 1986;65:113-23.
5. Meyer RD, Rosen P, Armstrong D. Phycomycosis complicating leukemia and lymphoma. Ann Intern Med 1972;77:871-9.
6. Bruck HM, Nash G, Stein JM, Lindberg RB. Studies on the occurrence and significance of yeasts and fungi in the burn wound. Ann Surg 1972;176:108-10.
7. Hammer GS, Bottone EJ, Hirschman SZ. Mucormycosis in a transplant recipient. Am J Clin Pathol 1975;64:389-98.
8. Johnson PC, Satterwhite TK, Monheit JE, Parks D. Primary cutaneous mucormycosis in trauma patients. J Trauma 1987;27:437-41.
9. Rabin ER, Lundberg GD, Mitchell ET. Mucormycosis in severely burned patients: report of two cases with extensive destruction of the face and nasal cavity. N Engl J Med 1963;264:1286-9.
10. Vazquez JA, Sobel JD. Fungal infections in diabetes. Infect Dis Clin North Am 1995;9:97-116.
11. Sugar AM. Mucormycosis. Clin Infect Dis 1992;14(Suppl 1):S126-9.
12. Tierney MR, Baker AS. Infections of the head and neck in diabetes mellitus. Infect Dis Clin North Am 1995;9:195-216.
13. Pillsbury HC, Fischer ND. Rhinocerebral mucormycosis. Arch Otolaryngol 1977;103:600-4.
14. Pruitt BAJ. Phycomycotic infections. Probl Gen Surg 1984;1:664-78.
15. Nash G, Foley FD, Goodwin MNJ, Bruck HM, Greenwald KA, Pruitt BAJ. Fungal burn wound infection. JAMA 1971;215:1664-6.
16. Burdge JJ, Rea F, Ayers L. Noncandidal, fungal infections of the burn wound. J Burn Care Rehabil 1988;9:599-601.
17. Blitzer A, Lawson W, Meyers BP, Biller HF. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope 1980;90:635-48.
18. Smitherman KO, Peacock JEJ. Infectious emergencies in patients with diabetes mellitus. Med Clin North Am 1995;79:53-77.
19. Mowat A, Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med 1971;284:621-7.
20. Bagdade ID, Root RK, Bulger RI. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 1974;23:9-15.
21. Nielson CP, Hindson DA. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 1989;38:1031-5.
22. Alexander JW. Mechanism of immunologic suppression in burn injury. J Trauma 1990;30:S70-5.
23. Lehrer RI, Howard DH, Sypherd PS. Mucormycosis. Ann Intern Med 1980;93:93-108.
24. Press GA, Weindling SM, Hesselink JR, Ochi JW, Harris JP. Rhinocerebral mucormycosis: MR manifestations. J Comput Assist Tomogr 1988;12:744-9.
25. Meyer RD, Armstrong D. Mucormycosis-changing status. CRC Crit Rev Clin Lab Sci 1973;4:421-51.
26. von Pohle WR. Disseminated mucormycosis presenting with lower extremity weakness. Eur Respir J 1996;9:1751-3.
27. Tang D, Wang W. Successful cure of an extensive burn injury complicated with mucor wound sepsis. Burns 1998;24:72-3.
28. Strasser MD, Kennedy RJ, Adam RD. Rhinocerebral mucormycosis. Therapy with amphotericin B lipid complex. Arch Intern Med 1996;156:337-9.
29. Ericsson M, Anniko M, Gustafsson H, Hjalt CA, Stenling R, Tamvik A. A case of chronic progressive rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery. Clin Infect Dis 1993;16:585-6.
30. Raj P, Vella EJ, Bickerton RC. Successful treatment of rhinocerebral mucormycosis by a combination of aggressive surgical debridement and the use of systemic liposomal amphotericin B and local therapy with nebulized amphotericin - a case report. J Laryngol Otol 1998;112: 367-70.
31. Adler DE, Milhorat TH, Miller JI. Treatment of rhinocerebral mucormycosis with intravenous interstitial, and cerebrospinal fluid administration of amphotericin B: case report. Neurosurgery 1998;42:644-8.
32. Moses AE, Rahav G, Barenholz Y, Elidan J, Azaz B, Gillis S, et al. Rhinocerebral mucormycosis treated with amphotericin B colloidal dispersion in three patients. Clin Infect Dis 1998;26:1430-3.
33. Sahin B, Paydas S, Cosar E, Bicakci K, Hazar B. Role of granulocyte colony-stimulating factor in the treatment of mucormycosis. Eur J Clin Microbiol Infect Dis 1996; 15:866-9.